Nektar Therapeutics Ownership & Insider Activity

Nektar Therapeutics (NKTR) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 8.3% of shares outstanding. Institutional investors hold 44.5%. Over the past 90 days, insiders made 2 sales worth $43K.

Shares Outstanding

34.143M

Shares Float

30.975M

Insider Shares Owned

2.836M

Insider % Owned

8.3%

Institutional Shares Held

15.181M

Institutional % Held

44.5%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$43K total

Net Activity

Net Selling

Net Value (90d)

-$43K

Nektar Therapeutics Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Aug 18, 2026	Jonathan Zalevsky	CHIEF R&D OFFICER	SELL	186.000	$71.98	$13K
Aug 18, 2026	HOWARD ROBIN	PRESIDENT & CEO	SELL	418.000	$71.98	$30K
Jun 30, 2026	Jonathan Zalevsky	CHIEF R&D OFFICER	SELL	5.681K	$70.00	$398K
Jun 16, 2026	HOWARD ROBIN	PRESIDENT & CEO	SELL	20.000K	$60.75	$1.2M
Jun 15, 2026	Jonathan Zalevsky	CHIEF R&D OFFICER	SELL	5.538K	$60.71	$336K
May 19, 2026	Jonathan Zalevsky	CHIEF R&D OFFICER	SELL	199.000	$65.51	$13K
May 19, 2026	HOWARD ROBIN	PRESIDENT & CEO	SELL	444.000	$65.51	$29K